Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma
Today 9:00 EST
From
Candel Therapeutics
Via
GlobeNewswire
Tickers
CADL
Pacific Eye Associates Selects Nextech
Today 9:00 EST
From
Nextech Systems, Inc.
Via
GlobeNewswire
Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
Today 9:00 EST
From
Kronos Bio, Inc.
Via
GlobeNewswire
Tickers
KRON
Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (ASH) Annual Meeting
Today 9:00 EST
From
Beam Therapeutics
Via
GlobeNewswire
Tickers
BEAM
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
Today 9:00 EST
From
Century Therapeutics, Inc.
Via
GlobeNewswire
Tickers
IPSC
Ichnos Glenmark Innovation (IGI) Announces First Presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/Refractory Multiple Myeloma (r/rMM) at Upcoming ASH Annual Meeting
Today 9:00 EST
From
Ichnos Glenmark Innovation
Via
GlobeNewswire
Pangea Launches Two New Advanced Materials
Today 9:00 EST
From
Pangea
Via
GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
Today 9:00 EST
From
Disc Medicine Inc
Via
GlobeNewswire
Tickers
IRON
ImCheck to Present Updated Data from the EVICTION Trial at the 39th Annual Meeting of the Society for Immunotherapy of Cancer
Today 9:00 EST
From
ImCheck Therapeutics SAS
Via
GlobeNewswire
John Snyder, Former BCD CEO and Travel Industry Leader, Joins Oversee’s Advisory Board
Today 9:00 EST
From
Oversee
Via
GlobeNewswire
Kaiser Aluminum Corporation to Participate in Baird’s 2024 Global Industrial Conference
Today 9:00 EST
From
Kaiser Aluminum Corporation
Via
GlobeNewswire
Tickers
KALU
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations
Today 9:00 EST
From
Autolus Therapeutics plc
Via
GlobeNewswire
Tickers
AUTL
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
Today 9:00 EST
From
C4 Therapeutics, Inc.
Via
GlobeNewswire
Tickers
CCCC
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
Today 9:00 EST
From
PrognomiQ
Via
GlobeNewswire
Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma
Today 9:00 EST
From
Affimed N.V.
Via
GlobeNewswire
Tickers
AFMD
PRIDE Industries Achieves AS9100 Certification, Strengthening its Position in Aerospace and Defense Manufacturing
Today 9:00 EST
From
PRIDE Industries
Via
GlobeNewswire
kama.ai Supports Community Circle’s OWL Project with Responsible AI for Sustainable Water Solutions
Today 9:00 EST
From
kama.ai
Via
GlobeNewswire
Auron to Present New Preclinical Data for AUTX-703 at 2024 ASH Meeting
Today 9:00 EST
From
Auron Therapeutics Inc.
Via
GlobeNewswire
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
Today 9:00 EST
From
NeurAxis, Inc.
Via
GlobeNewswire
FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment
Today 9:00 EST
From
General Fusion
Via
GlobeNewswire
LPL Financial Welcomes GWC Financial Advisors to Linsco Channel
Today 8:56 EST
From
LPL Financial Holdings, Inc.
Via
GlobeNewswire
Tickers
LPLA
Itron Enhances Intelligent Connectivity Suite for Utilities with eSIM Technology
Today 8:45 EST
From
Itron, Inc.
Via
GlobeNewswire
Tickers
ITRI
Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
Today 8:30 EST
From
Vaccinex, Inc.
Via
GlobeNewswire
Tickers
VCNX
Complete Solar Announces Preliminary Q3’24 Results
Today 8:30 EST
From
Complete Solar, Inc.
Via
GlobeNewswire
Tickers
CSLR
Martinrea International Inc. to Announce Third Quarter Results on November 12, 2024
Today 8:30 EST
From
Martinrea International Inc.
Via
GlobeNewswire
Tickers
TSX:MRE
Gaxos to Participate in The AI Summit New York on December 11th to December 12th in New York City
Today 8:30 EST
From
GAXOS.AI INC.
Via
GlobeNewswire
Tickers
GXAI
SIMPPLE Ltd. Comments on Plan to Regain Nasdaq Compliance
Today 8:30 EST
From
SIMPPLE Ltd.
Via
GlobeNewswire
Tickers
SPPL
Enovix Completes $100 Million Equity Offering
Today 8:30 EST
From
Enovix Corporation
Via
GlobeNewswire
Tickers
ENVX
Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Today 8:30 EST
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Tickers
INZY
Jones Soda Sets Third Quarter 2024 Conference Call for Wednesday, November 13, 2024, at 4:30 p.m. ET
Today 8:30 EST
From
Jones Soda Co.
Via
GlobeNewswire
Tickers
CSE:JSDA
JSDA
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.